Q1 2022 Holdings
Filed 2022-05-16 | 77 holdings | $84.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $21.7K | 865,000 | 0.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $22.3K | 2,489,894 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $22.9K | 1,087,807 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $23.1K | 1,375,982 | 0.0% |
| Helix Acquisition Corp | COM CL A | G4444C102 | $33.3K | 3,280,000 | 0.0% |
| Aerovate Therapeutics Inc | COM | 008064107 | $33.6K | 1,830,691 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $37.1K | 4,899,185 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $37.2K | 2,012,115 | 0.0% |
| Forma Therapeutics Hldgs Inc | SHS | 34633R104 | $37.8K | 4,068,351 | 0.0% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $42.1K | 3,002,199 | 0.1% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $45.4K | 4,682,874 | 0.1% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $50.9K | 1,995,066 | 0.1% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $57.2K | 1,125,000 | 0.1% |
| Greenlight Biosciencs Hlds P | COMMON STOCK | 39536G105 | $62.0K | 6,710,540 | 0.1% |
| Prometheus Biosciences Inc | COM | 74349U108 | $68.9K | 1,823,444 | 0.1% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $83.3K | 5,156,994 | 0.1% |
| Erasca Inc(ERAS) | COM | 29479A108 | $90.3K | 10,505,554 | 0.1% |
| Turning Point Therapeutics I | COM | 90041T108 | $99.3K | 3,700,000 | 0.1% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $1.6M | 392,167 | 1.9% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $2.3M | 1,154,424 | 2.8% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $5.2M | 90,045 | 6.1% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $5.9M | 50,000 | 7.0% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $11.2M | 1,547,181 | 13.3% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $12.0M | 712,079 | 14.3% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $14.1M | 3,170,872 | 16.8% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $14.7M | 400,000 | 17.5% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $15.9M | 1,568,909 | 18.9% |